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Abstract 
Purpose: To investigate the prevalence of qnr, intI, and intII genes in extended spectrum beta-
lactamase (ESBL)-producing Escherichia coli isolated from clinical samples in Kerman, Iran. 
Methods: A total of 127 E. coli were collected from clinical samples in Kerman hospitals. The antibiotic 
susceptibility test was performed using disc diffusion method, while the presence of ESBL-producing E. 
coli was determined by phenotypic confirmatory test. Furthermore, the presence of qnrA, qnrB, qnrS, 
intI, intII, and β-lactamase-encoding genes was detected by polymerase chain reaction (PCR). Finally, 
the data were analyzed and associations between different genes and antibiotic resistance were 
evaluated.  
Results: The highest and lowest rates of resistance were observed against ampicillin (72.4 %) and 
imipenem (2.3 %), respectively. Also, 41.7 % of the isolates produced ESBL-enzymes. The qnrS and 
genes were detected in 6.3 and 0.78 %, respectively, of the isolates, while qnrA gene was not detected 
in the current study. The results revealed that 64.5 and 10.2 % of isolates carried intI and intII genes, 
respectively. Data analysis showed a significant association between ESBL production and class I 
integrin gene in E. coli isolates. 
Conclusions: Due to the variation in the resistance patterns of E. coli against antibiotics in different 
geographical regions, antimicrobial treatments should be based on local experience. Also, the 
coexistence of ESBL and intI gene in the majority of E. coli isolates suggests that care should be taken 
in choosing antibiotic therapy. 
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Extended-spectrum β-lactamase (ESBLs) such 
as E. coli and Klebsiella pneumonia are 
frequently prevalent in the Enterobacteriaceae 
family [1,2]. In recent years, ESBL-producing E. 
coli has mostly been implicated in nosocomial 
infections [3]. ESBL-producing organisms are 
resistant not only to beta-lactams, but also to 
most other antibiotic families such as 
aminoglycosides and quinolones, and that results 
in the limitation of therapeutic options [3,4]. 
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ESBLs are enzymes commonly derived from 
TEM or SHV families of enzymes [4]. CTXM is 
also a concern and has become increasingly 
prevalent in the world since 1995 [5]. The 
emergence of quinolone resistance among 
human gram-negative pathogens is also of 
concern [6,7].  
 
Several mechanisms contribute to the resistance 
to quinolone antibiotics; plasmid-mediated 
quinolone resistance qnr genes are a common 
mechanism [8]. Although the qnr gene is 
associated only with low-level resistance to 
fluoroquinolones, the presence of the qnr gene 
along with chromosomal mutations can 
contribute to high levels of resistance. It has also 
been suggested that the relationship between 
qnr and ESBLs is co-associated with ESBL-
encoding genes. High levels of quinolone 
resistance in clinical strains of E. coli and other 
ESBL-producing bacteria have been reported in 
various studies [9-11]. However, the majority of 
recent studies on ESBL genes found that ESBL 
genes were located on integrons. Therefore, 
ESBLs can be located on integron genes and 
easily transferred into various bacteria [12].  
 
The prevalence of antibacterial resistance among 
E. coli species is an important problem. 
Antimicrobial resistance patterns are different in 
qnr and ESBL-producing species [6,7,13]. The 
main purpose of the current study was to detect 
the relationships between ESBL and qnr and 
between ESBL and integrons (intI and intII) to 
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In the current study, 127 E. coli from urine, blood, 
wound, and other bodily fluids were collected 
from Kerman hospitals. All 127 E. coli were 
identified biochemically using standard methods 
including motility, indole production, negative 
citrate test, glucose, sucrose, and lactose 
fermentation in TSI agar, and positive MR 
reaction in MRVP medium. After E. coli was 
identified, the isolates were evaluated for 
antimicrobial resistance. 
 
Antimicrobial susceptibility test and β-
lactamase determination 
 
Antibiotic susceptibility tests were carried out 
using the disc diffusion method according to 
Clinical and Laboratory Standard Institute 
guidelines (CLSI). Antibiotic discs including 
ampicillin, ceftriaxone, cefotaxime, ceftazidime, 
co-trimoxazole, nalidixic acid, ciprofloxacin, 
gentamicin, amikacin, and imipenem were used. 
ESBL-producing E. coli was determined using 
the phenotypic confirmatory test. The phenotypic 
test was performed using cefotaxime-clavulanic 
acid or ceftazidime-clavulanic acid as two-disk 
synergism versus ceftazidime or cefotaxime 
alone. If the inhibition zone around the synergism 
disks compared with ceftazidime or cefotaxime 
alone was ≥ 5mm, then these species was found 
to be ESBL-producing. E. coli (ATCC 25922) was 
used as a negative control to determine antibiotic 
susceptibility. 
 
Detection of qnr, intI, intII, and β-lactamase-
encoding genes 
 
The presence of intI, intII, qnrA, qnrB, qnrS, bla-
TEM, bla-SHV, and bla-CTXM genes was 
detected by standard PCR amplification. First, E. 
coli colonies were grown in MacConkey agar and 
then transferred into 1 ml of water in an 
Eppendorf tube to be boiled. After 15 mins 
boiling, DNA templates were extracted for PCR 
amplification. PCR reactions were performed in a 
final volume of 25 µL using 3 µL of DNA solution, 
12.5 µL Qiagen HotStar Taq polymerase Master 
Mix, 10 pmol primer, and water. PCR cycling 
conditions were as follows: denaturation step at 
94 oC for 5 min, followed by 30 cycles of 
denaturation at 94 oC for 1 min, extension at 72 
for 40 s, and the final extension step at 72 oC for 
5 min. All primers used in the current study are 
listed in Table 1.  PCR products were detected 
using electrophoresis on a 1 % agarose gel. The 
agarose gel was stained with ethidium bromide. 
The agarose gel was illuminated by UV and then 
analyzed. Figures 1 and 2 demonstrate the 
locations of the genes on the agarose gel. 
Klebsiella pneumonia (ATCC 700603) was used 
as the positive control for bla-SHV and bla-CTXM 
genes. E. coli (ATCC 35218) was also used as 
the positive control for the bla-TEM gene, and E. 
coli (ATCC 25922) was considered as the 
negative control. Acinetobacter baumannii 
(TMU1, TMU2) were used as the positive 
controls for integron classes I and II. 
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Furthermore, E. coli J53 strains containing 
pMG252, pMG298, and pMG306 were used as 
qnrA, qnrB, and qnrS-positive controls, 
respectively. 
 
Statistical analysis  
 
Data was analyzed using SPSS, version 22 and 
is presented as mean ± standard deviation (SD). 
Associations between different genes and 
antibiotic resistance were also evaluated using 





The findings indicate that the resistance rates of 
ESBL-producing isolates to all antibiotics were 
higher than those of non-ESBL-producing 
isolates. In the current study, 127 E. coli were 
isolated from a range of clinical specimens 
including the bodily fluids of patients with urinary 
tract, blood, wound, and other types of infection. 
E. coli isolates were most frequently isolated 
from patients with urinary tract infection (89.7 %); 
the isolated samples of blood, wound, and 
bronchial fluid were 3 (2.3 %), 6 (4.7 %), and 5 
(3.9 %), respectively. Of all 127 samples, 82 
(64.5 %) were isolated from females compared to 
45 (35.4 %) samples isolated from males. As 
shown in Table 2, even though imipenem was 
the most effective antibiotic against E. coli 
isolates, susceptibility to amikacin, ciprofloxacin, 
and gentamicin was also high. Ninety-two 
isolates (72.4 %) were resistant to ampicillin, a 
higher percentage than for any other antibiotic. 
Resistance to co-trimoxazole and nalidixic acid 
was also significant. E. coli clinical isolates 
showed variable susceptibility to different 
antibiotics. For example, isolates recovered from 
urinary tract infections were more resistant to 
ciprofloxacin and gentamicin than others, but 
resistance to imipenem, ampicillin, and 
ceftriaxone was higher in wound and bronchial 
fluid samples. Details of the antibiotic 
susceptibility tests are presented in Table 2.  
 
The results of this study further showed that 
various isolates from urinary tract, blood, and 
wound infections as well as other bodily fluids 
were significantly associated with the prevalence 
of ESBLs (Table 3). One hundred percent and 
33.6 % of E. coli isolates from wound and urinary 
tract infections were ESBLs-containing, 
respectively (P < 0.05). ESBL-producing isolates 
were determined using the phenotypic disk 
technique in which 53 (41.7 %) isolates were 
found to produce ESBL enzymes. After PCR 
detection, all phenotypically-positive isolates 
contained ESBL genes. The bla-TEM gene was 
the major ESBL type observed in 86.7 % of 
ESBL-producing isolates. Among 53 identified 
ESBL-producing E. coli, 81.1 % and 5.6 % were 
bla-CTXM and bla-SHV, respectively. However, 
the majority of ESBL-producing isolates were 
susceptible to imipenem (94.4 %) and amikacin 
(90.6 %). 
 
Table 1: Primers were used for different genes 
 
 
Genes         Primer sequence (5’-3’)                   Product size( bp) Tm (ċ) Referenc
e 
bla-SHV F: TCAGCGAAAAACACCTTG         
              
R:TCCCGCAGATAAATCACC 
471 56 [15] 
bla-TEM F-GAGTATTCAACATTTCCGTGTC 
R:TAATCAGTGAGGCACCTATCTC 
861 59 [15] 
bla-CTXM F-CGCTTTGCGATGTGCAG                             
R:ACCGCGATATCGTTGGT 
550 59 [16] 
qnrA F:GATCGGCAAAGGTTAGGTCA    
R:ATTTCTCACGCCAGGATTTG 
627 53 [17] 
qnrB F:GATCGTGAAAGCCAGAAAGG    
R:ACGATGCCTGGTAGTTGTCC 
562 53 [17] 
qFnrS F:AGTGATCTCACCTTCACCGC                                                                   
R: CAGGCTGCAATTTTGATACC 
550 53 [17] 
intI F:CAGTGGACATAAGCCTGTTC     
R:CCCGAGGCATAGACTGTA 
160 55 [18] 
intII F:TTGCGAGTATCCTAACCTG         
R:TTACCTGCACTGGATTAAGC 
789 55 [18] 
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Antibiotic susceptibility results also demonstrated 
that antibiotic resistance patterns of ESBL-
producing E. coli are different from non-ESBL 
ones. ESBL-positive E. coli showed high level 
resistance (>80 %) to third-generation 
cephalosporins, but resistance to third-
generation cephalosporins in ESBL-negative E. 
coli was low. Furthermore, resistance to 
fluoroquinolone antibiotics was higher in ESBL-
positive E. coli than in ESBL-negative E. coli. In 
this study, a direct relationship between the 
presence of bla-CTXM and bla-TEM genes in E. 
coli and resistance to some antibiotics such as 
gentamicin, ciprofloxacin, ampicillin, ceftriaxone, 
ceftazidime, cefotaxime, imipenem, and co-
trimoxazole were observed (P < 0.05). Isolates 
producing bla-CTXM were more resistant than 
those producing bla-TEM and bla-SHV. For 
example, resistance to ciprofloxacin was higher 
in bla-CTXM-producing isolates than in the 
others (p < 0.05). 
 
Overall, the isolates were screened for the 
presence of the qnr gene by PCR; 8 (7.2 %) 
isolates containing this gene were observed. 
qnrS was the most dominant gene among the 
qnr genes. Of the 8 qnr-producing E. coli 
isolates, only one isolate produced qnrB, but 
qnrS was detected in all of the 8 isolates. No 
qnrA gene was identified in this study. After 
analysis, the data showed that 3 (37.5 %) qnr-
producing isolates contained ESBL genes as 
well, but 5 (62.5 %) isolates were without these 
genes. The qnr-producing isolates were found in 
those E. coli-producing ESBLs that had both bla-
TEM and bla-CTXM genes, but they were not 
found in bla-SHV-producing E. coli.  
 
Based on data analysis, there was no significant 
association between ESBL and the qnr gene. 
Interestingly, the prevalence of the intI gene was 
observed in the majority of isolates such that 82 
(64.5 %) isolates presented this gene, but only 
13 (10.2 %) of the 127 E. coli isolates carried the 
intII gene. Class I integrons were more common 
in ESBL isolates than in non-ESBL isolates. In 
this study, a significant association between 
ESBL and integron class I was observed (P < 
0.05). Conversely, no association was found 
between integron class II and ESBL genes. 
 
 
Figure 1: Agarose gel electrophoresis of 
representative intI gene detected in E. coli 
isolates. Note: DNA ladder was consist of size 
marker range 100 - 1500 bp. 1 = ladder, 2 = posi-
tive control, 3 = negative control. Other  numbers 
indicate the isolates showing intI gene 
 





Resistance Intermediate Sensitive 
Ampicillin 96.2 55.40 72.40 2.30 25.10 
Ceftriaxone 81.1 18.90 40.90 0.70 58.20 
Cefotaxime 84.9 5.40 42.01 3.30 54.60 
Ceftazidime 92.4 4.00 31.80 8.60 59.40 
Co-trimoxazole 95.5 54.04 70.80 2.60 26.70 
Nalidixic acid 80.0 28.0 51.10 3.10 45.60 
Ciprofloxacin 54.6 6.70 26.90 3.90 69.04 
Gentamicin 33.9 1.30 15.70 2.30 81.40 
Amikacin 9.40 5.40 7.08 8.60 84.20 
Imipenem 5.60 0.00 2.30 2.40 95.0 
 




Integron Class I Integron Class II 
Total ESBLs Non- 
ESBLs 
Total ESBLs Non- 
ESBLs 
Urine 73 29 44 13 6 7 
Wound 5 5 0 0 0 0 
Blood 1 1 0 0 0 0 
Fluid 3 3 0 0 0 0 
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Figure 2: Agarose gel electrophoresis of 
representative bla-TEM and bla-CTXM genes 
detected in E. coli isolates. Note: 1 = ladder, 2 = 
positive control, 3 = negative control. 4 and 5 
indicate the isolates showing bla-TEM and bla-




In the current sudy, ESBL-producing E. coli was 
found to be more than 40 % in the clinical 
samples. In addition, the results suggest the 
emergence of a high frequency of ESBLs 
inclinical isolates, which may have been caused 
by the excessive use of broad-spectrum 
antibiotics in hospitals. In fact, resistance to β-
lactam antibiotics and cephalosporins was more 
common than to other antibiotics because of the 
lack of attention paid to antibiotic consumption. 
Ampicillin and co-trimoxazole had the highest 
percentages of resitance, but the highest 
percentages of susceptibility were observed for 
imipenem, amikacin, ciprofloxacin, and 
gentamicin. The current findings are in 
congruence with those of other studies 
conducted by Calbo et al. and Mehrgan et al 
[4,18]. 
 
It is noteworthy that in this study, ESBL enzymes 
were detected in the majority of isolates in which 
bla-TEM was the most common ESBL isolated 
from clinical samples. Furthermore, the 
prevalence of bla-CTXM and bla-SHV in E. coli 
isolates was high. Table 2 demonstrates that the 
resistance rate of ESBL-producing isolates to all 
antibiotics was higher than that of non-ESBL-
producing ones, especially to ampicillin, co-
trimoxazole, and ceftazidime. These results are 
congruent with several studies conducted in Iran 
and other countries. According to a study done 
by Zaniani et al, ESBL was found in 43.9 % of 
isolates, demonstrating the prevalence of ESBL 
in E. coli isolates [19]. The results of Zaniani et 
al. corroborate those of the current study. Also, 
Calbo et al demonestrated the prevalance of 
ESBL in E. coli isolates and detected TEM (60 
%), SHV (16 %), and CTX-M (24 %) were also 
detected in these bacteria [18].  
 
Some studies in Iran have demonstrated that 
ESBLs have been increasing during recent 
years. For example, Pakzad et al and Nakhaei 
Moghaddam et al reported ESBL-containing E. 
coli in 28 % and 33 % of isolates, respectively 
[20,21]. Based on the results of the above-
named studies, the increase in ESBL genes 
found in E. coli isolates in the last few years is a 
major problem. The current study found the 
prevalence rates of the intI and intII genes in E. 
coli isolates to be 82 (64.5 %) and 13 (10.2 %), 
respectively.  
These results are similar to results obtained by 
Elisabete Machado et al [12]. Moreover, in a 
study by Aziz Japoni et al, the existence of 
integrons was confirmed in 44.8 % of E. coli 
isolates, and the prevalence of integrons was 
about half the amount obtained in the current 
study [22]. The prevalence of integrons was 55.5 
% in Mexico and 26.1 % in Turkey [23,24]. These 
results confirm that the prevalence of integron 
genes varies between Iran and other parts of the 
world. This resistance can probably be 
associated with a combination of ESBL genes 
and integron class I genes.  
 
Integrons play an important role in the antibiotic 
resistance of clinical E. coli strains, and they are 
able to capture, integrate, and express those 
gene cassettes encoding antibiotic resistance 
[12]. In this study, a significant association 
between ESBLs and integron class I genes was 
observed as it was in several other studies the 
results of which agree with the current results 
[12,25]. Therefore, it can be said that ESBLs 
genes are located on class I integrons.  
 
Nevertheless, 8 (7.2 %) qnr-positive E. coli 
isolates were identified among a total of 127 
clinical isolates. Although the prevalance of qnr 
genes was low, this plasmid-borne mechanism is 
a major concern for increasing antibiotic 
resistance in other isolates. There results have 
also been confirmed by other investigators, such 
as Mammeri et al. who reported that qnr genes 
were only found in 0.3 % of E. coli isolates [13]. 
Similar to the current study, Jeong et al. 
demonstrated that the prevalence of qnr genes in 




The findings of this study indicate that amikacin, 
imipenem, ciprofloxacin, and gentamicin are the 
most appropriate oral antibiotics for treating 
ESBL infections in Kerman, Iran, but ampicillin is 
not a good choice for treating E. coli infections. 
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The high prevalence of ESBL and intI genes in 
the hospital setting can cause antibiotic 
resistance. Since available treatment options are 
limited, antibiotic control policies combined with 
the implementation of infection control measures 
are of utmost importance. Furthermore, 
adherence to health recommendations in 
hospitals and appropriate prescribing of 
antibiotics can minimize antibiotic resistance 
resulting from ESBLs, integrons, and qnr-borne 
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